The study will assess the acceptability and feasibility of a randomised controlled trial of 6-12 sessions of remotely-delivered Acceptance and Commitment Therapy (ACT) versus waitlist control. Waitlist control will involve a delay in the offer of ACT sessions for 12 weeks. Participants may access all services as usual in this time. Follow-up assessments will be conducted at 12-, 24 and 48 weeks post-randomisation to measure effectiveness.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Treatment completion rate
Timeframe: Assessed at 3-month follow-up.
Treatment completion rate
Timeframe: Assessed at 6-month follow-up
Session attendance rate
Timeframe: Assessed at 3-month follow-up
Session attendance rate
Timeframe: Assessed at 6-month follow-up
The credibility/expectancy questionnaire
Timeframe: Assessed at baseline
The credibility/expectancy questionnaire
Timeframe: Assessed at session 2
The experience of service questionnaire
Timeframe: Assessed at 3-month follow-up
The experience of service questionnaire
Timeframe: Assessed at 6-month follow-up